Health and Wellness
It is a home-based programme with 10 self-paced modules.
The Inspire 3 will be available worldwide in September, while the higher-end Versa 4 and Sense 2 will be available in the fall.
Dozee's sensor-based technology uses AI to track vital parameters.
Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
The newly public company, now trading on Nasdaq under the ticker symbol "AKLI," will use the proceeds from the transaction to launch EndeavorRx, its video game-like digital therapeutic for children with ADHD.
One of the projects will develop a digital navigator to support people with chronic conditions.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.